Published in Tumour Biol on July 07, 2012
Salinomycin: a novel anti-cancer agent with known anti-coccidial activities. Curr Med Chem (2013) 1.03
Chaetoglobosin K induces apoptosis and G2 cell cycle arrest through p53-dependent pathway in cisplatin-resistant ovarian cancer cells. Cancer Lett (2014) 0.85
Gramicidin A: A New Mission for an Old Antibiotic. J Kidney Cancer VHL (2015) 0.75
Salinomycin Suppresses PDGFRβ, MYC, and Notch Signaling in Human Medulloblastoma. Austin J Pharmacol Ther (2014) 0.75
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08
Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med (2007) 2.49
Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology (2003) 2.27
Effect of training-sample size and classification difficulty on the accuracy of genomic predictors. Breast Cancer Res (2010) 2.26
Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. Contraception (2006) 1.90
Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice. Hepatology (2005) 1.73
Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice. Gastroenterology (2003) 1.66
Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43. Mol Cell Biol (2009) 1.61
Psychological aspects of fertility preservation in men and women affected by cancer and other life-threatening diseases. Hum Reprod Update (2009) 1.49
A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression. J Clin Psychiatry (2011) 1.32
Digital PCR: a powerful new tool for noninvasive prenatal diagnosis? Prenat Diagn (2008) 1.24
Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer. PLoS One (2011) 1.21
Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors. Mol Cancer (2009) 1.20
Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial. Eur J Obstet Gynecol Reprod Biol (2009) 1.18
Evaluation of computer-aided diagnosis on a large clinical full-field digital mammographic dataset. Acad Radiol (2008) 1.17
An overview of biomarkers for the ovarian cancer diagnosis. Eur J Obstet Gynecol Reprod Biol (2011) 1.16
Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer. BMC Cancer (2009) 1.14
Women's perceptions and reasons for choosing the pill, patch, or ring in the CHOICE study: a cross-sectional survey of contraceptive method selection after counseling. BMC Womens Health (2013) 1.11
The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers. Tumour Biol (2012) 1.10
Genetic investigations of CFTR mutations in congenital absence of vas deferens, uterus, and vagina as a cause of infertility. J Androl (2008) 1.05
High-throughput hacking of the methylation patterns in breast cancer by in vitro transcription and thymidine-specific cleavage mass array on MALDI-TOF silico-chip. Mol Cancer Res (2008) 1.05
Sexual dysfunction after premenopausal stage I and II breast cancer: do androgens play a role? J Sex Med (2008) 1.04
Mitochondrial DNA content in paired normal and cancerous breast tissue samples from patients with breast cancer. J Cancer Res Clin Oncol (2009) 1.03
Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study. Circ Arrhythm Electrophysiol (2014) 1.02
Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease. Anticancer Res (2008) 1.01
Epigenetics of ovarian cancer: from the lab to the clinic. Gynecol Oncol (2010) 1.01
Correlation of telomere length shortening with promoter methylation profile of p16/Rb and p53/p21 pathways in breast cancer. Mod Pathol (2010) 1.01
Gender differences in physicians' communicative skills and their influence on patient satisfaction in gynaecological outpatient consultations. Soc Sci Med (2008) 0.98
Redox-neutral α-cyanation of amines. J Am Chem Soc (2012) 0.98
Methylation signature of lymph node metastases in breast cancer patients. BMC Cancer (2012) 0.98
Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial. Br J Clin Pharmacol (2003) 0.97
Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations. Hum Mol Genet (2010) 0.95
Cell-free DNA in the circulation as a potential cancer biomarker. Anticancer Res (2011) 0.95
New trends in molecular biomarker discovery for breast cancer. Genet Test Mol Biomarkers (2009) 0.92
Women's sexual desire and arousal disorders. J Sex Med (2010) 0.91
MALDI-TOF mass array analysis of RASSF1A and SERPINB5 methylation patterns in human placenta and plasma. Biol Reprod (2010) 0.91
A rapid and accurate approach to identify single nucleotide polymorphisms of mitochondrial DNA using MALDI-TOF mass spectrometry. Clin Chem Lab Med (2008) 0.91
Significant correlation between maternal body mass index at delivery and in the second trimester, and second trimester circulating total cell-free DNA levels. Reprod Sci (2008) 0.90
Simultaneous quantitative assessment of circulating cell-free mitochondrial and nuclear DNA by multiplex real-time PCR. Genet Mol Biol (2009) 0.90
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for genotyping of human platelet-specific antigens. Transfusion (2008) 0.89
Intelligent nanomaterials for medicine: carrier platforms and targeting strategies in the context of clinical application. Nanomedicine (2013) 0.89
Simultaneous isolation of DNA, RNA, and proteins for genetic, epigenetic, transcriptomic, and proteomic analysis. J Proteome Res (2009) 0.89
Two preferentially expressed proteins protect vascular endothelial cells from an attack by peptide-specific CTL. J Immunol (2012) 0.89
Circulating cell-free DNA as a potential biomarker for minimal and mild endometriosis. Reprod Biomed Online (2009) 0.89
Questionnaires for assessment of female sexual dysfunction: a review and proposal for a standardized screener. J Sex Med (2011) 0.89
Identification of antenatal depression in obstetric care. Arch Gynecol Obstet (2011) 0.88
Contraceptive counselling and factors affecting women's contraceptive choices: results of the CHOICE study in Austria. Reprod Biomed Online (2011) 0.87
Current understanding of mitochondrial DNA in breast cancer. Breast J (2009) 0.87
Effects of relaxation on psychobiological wellbeing during pregnancy: a randomized controlled trial. Psychoneuroendocrinology (2010) 0.87
Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation. Oncol Rep (2013) 0.87
Effect of nifedipine versus telmisartan on prevention of atrial fibrillation recurrence in hypertensive patients. Hypertension (2013) 0.87
Emergency hormonal contraception in Switzerland: a comparison of the user profile before and three years after deregulation. Eur J Contracept Reprod Health Care (2009) 0.87
Quantitative assessment and classification of tissue-based biomarker expression with color content analysis. Arch Pathol Lab Med (2012) 0.86
Examination of maternal plasma erythropoietin and activin A concentrations with regard to circulatory erythroblast levels in normal and preeclamptic pregnancies. Fetal Diagn Ther (2006) 0.86
Recent progress in non-invasive prenatal diagnosis. Semin Fetal Neonatal Med (2008) 0.86
Maternal and neonatal infections and obstetrical outcome in water birth. Eur J Obstet Gynecol Reprod Biol (2006) 0.86
Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach. Stat Med (2014) 0.86
Maternal laboratory stress influences fetal neurobehavior: cortisol does not provide all answers. J Matern Fetal Neonatal Med (2010) 0.86
Fetal response to abbreviated relaxation techniques. A randomized controlled study. Early Hum Dev (2010) 0.86
Predictors of late recurrence of atrial fibrillation after catheter ablation. Int J Cardiol (2011) 0.85
Frequency and focus of sexual history taking in male patients--a pilot study conducted among Swiss general practitioners and urologists. J Sex Med (2007) 0.85
Identification of a critical novel mutation in the exon 1 of androgen receptor gene in 2 brothers with complete androgen insensitivity syndrome. J Androl (2008) 0.85
Effects of sex hormones in oral contraceptives on the female sexual function score: a study in German female medical students. Contraception (2010) 0.84
The entire small intestine mediates the changes in glucose homeostasis after intestinal surgery in Goto-Kakizaki rats. Ann Surg (2012) 0.84
Integrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatment. PLoS One (2011) 0.84
High expression of CCL20 is associated with poor prognosis in patients with hepatocellular carcinoma after curative resection. J Gastrointest Surg (2011) 0.84
Post-traumatic symptoms after childbirth: what should we offer? J Psychosom Obstet Gynaecol (2006) 0.84
Proteomics and biomarkers for ovarian cancer diagnosis. Ann Clin Lab Sci (2010) 0.83
Size fractionation of cell-free DNA in maternal plasma improves the detection of a paternally inherited beta-thalassemia point mutation by MALDI-TOF mass spectrometry. Fetal Diagn Ther (2009) 0.83
Review of clinical experience with estradiol in combined oral contraceptives. Contraception (2010) 0.83
Previous birth experience and birth anxiety: predictors of caesarean section on demand? J Psychosom Obstet Gynaecol (2009) 0.83
Mutations of mitochondrial DNA as potential biomarkers in breast cancer. Anticancer Res (2011) 0.81
Designing switchable nanosystems for medical application. J Control Release (2012) 0.81
How do obstetric variables influence the dimensions of the birth experience as assessed by Salmon's item list (SIL-Ger)? Eur J Obstet Gynecol Reprod Biol (2004) 0.81
Prognostic significance of mammalian sterile 20-like kinase 1 in breast cancer. Tumour Biol (2013) 0.81
The challenge of talking about sex: the importance of patient-physician interaction. Maturitas (2009) 0.80
High levels of circulatory erythroblasts and cell-free DNA prior to intrauterine fetal death. Prenat Diagn (2006) 0.80
Specificity of methylation assays in cancer research: a guideline for designing primers and probes. Obstet Gynecol Int (2010) 0.80
Real-time quantitative polymerase chain reaction measurement of male fetal DNA in maternal plasma. Methods Mol Med (2007) 0.80
Communication skills training in obstetrics and gynaecology: whom should we train? A randomized controlled trial. Arch Gynecol Obstet (2007) 0.80
High throughput non-invasive determination of foetal Rhesus D status using automated extraction of cell-free foetal DNA in maternal plasma and mass spectrometry. Arch Gynecol Obstet (2008) 0.80
Maternal smoking: effect on circulating cell-free fetal and total DNA levels in maternal plasma from the second trimester. Obstet Gynecol (2007) 0.80
Is sex just fun? How sexual activity improves health. J Sex Med (2009) 0.80
Cognitive-behavioural group intervention for climacteric syndrome. Psychother Psychosom (2006) 0.79
Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia. Prenat Diagn (2006) 0.79
Antenatal psychobiological predictors of psychological response to childbirth. J Am Psychiatr Nurses Assoc (2011) 0.79
PLAC4 and beta-HCG mRNA levels are not altered in the maternal circulation of pregnancies with trisomy 21. Prenat Diagn (2008) 0.79
Do gynecologists talk about sexual dysfunction with their patients? J Sex Med (2014) 0.78